We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Chris Karapetis MBBS, FRACP, MMedSc

Prof Chris Karapetis MBBS, FRACP, MMedSc

Network Clinical Director (Cancer Services), Southern Adelaide Local Health Network, Head, Department of Medical Oncology and Director, Clinical Research in Medical Oncology, Flinders Medical Centre and Flinders University| Bedford Park | South Australia

Professor Chris Karapetis is Network Director for Cancer Services in the Southern Area Local Health Network of Adelaide, and Head of the Department of Medical Oncology at the Flinders Medical Centre. He is also the Director of Clinical Research in Medical Oncology at the Flinders Medical Centre and the Flinders Centre for Innovation in Cancer, Flinders University. He practices as a senior consultant medical oncologist at the same institution where he was instrumental in the establishment of a Clinical Research Unit.

Professor Karapetis has been the principal investigator on over 160 clinical trials and has published over 250 papers. He has established research interests in the areas of lung cancer, gastro-intestinal malignancy, molecular targeted therapies, predictive biomarkers, epidemiology, and clinical research methodology.

Professor Karapetis is involved in research conducted through the Australasian Gastrointestinal Trial Group (AGITG) and the Australian Lung Trials Group (ALTG). He is Chair of the Australia and Asia Pacific Clinical Research Development (ACORD) Initiative. He is also Chair of the AGITG Lower GI Working Group. He is current member of the Cancer Council SA Cancer Research Committee. He is a former Chair of the Gastrointestinal Group of the Clinical Oncology Society of Australia (COSA) and the Medical Oncology Group of Australia (MOGA), a past board member of COSA, and has served on NHMRC Grant Review Panels.